Skip to main content

Elizabeth Taylor

Equibles does not estimate personal net worth.

Get an email with a short summary when Sanara MedTech Inc. publishes a filing, an earnings call transcript or a press release.

Get SMTI alerts

About Elizabeth Taylor

Elizabeth Taylor is recorded as CFO at Sanara MedTech Inc. (SMTI). Sanara MedTech Inc. reported in an 8-K filed January 22, 2025 that Elizabeth Taylor was appointed Chief Financial Officer, effective January 15, 2025. The proxy statement of Sanara MedTech Inc. reports total compensation of $637,054 for Elizabeth Taylor in fiscal 2025, including a base salary of $240,545. Elizabeth Taylor has spoken on 5 earnings calls across 1 company, most recently for Sanara MedTech Inc. on May 12, 2026. Sanara MedTech Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Sanara MedTech Inc. includes Ronald T. Nixon (CEO), Seth D. Yon (CEO and Board Member), Seth Yon (CEO and Board Member) and 7 others.

“Elizabeth Taylor has been appointed to the position of Chief Financial Officer.”
Sanara MedTech Inc. Form 8-K, filed January 22, 2025 · Read the filing

Elizabeth Taylor on recent calls

“Net revenue in the first quarter of 2026 increased $4.4 million or 19% when compared to the first quarter of 2025, primarily due to increased sales of soft tissue repair products including CellerateRX Surgical and BIASURGE as Seth mentioned before.”
CFO, Sanara MedTech Inc. Q1 FY2026 Earnings Call ·
“I will begin by reiterating that the operations of THP, which were previously reported as the THP segment, have been classified as discontinued operations for the three months and full years ended December 31st, 2025 and 2024.”
CFO, Sanara MedTech Inc. Q4 FY2025 Earnings Call ·
“I will begin by reiterating that the operations of THP, which were previously reported as the THP segment, have been classified as discontinued operations for the 3 and 9 months ended September 30, 2025 and 2024.”
CFO, Sanara MedTech Inc. Q3 FY2025 Earnings Call ·
“Given that Ron covered our revenue results for the quarter, I'll begin with gross profit. Note that all percentage changes referenced throughout my remarks are compared to the prior year period.”
CFO, Sanara MedTech Inc. Q2 FY2025 Earnings Call ·
“I will begin my remarks at the gross profit line, since Ron discussed our quarterly revenue performance. Unless otherwise specified, all growth rates referenced during my prepared remarks are on a year-over-year basis.”
CFO, Sanara MedTech Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Sanara MedTech Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Sanara MedTech Inc. (SMTI) $240,545 $637,054

Recent activity